ASHTON FOSTER: Open Payments
NPI 1194440917 · DOUGLASVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,764 in 82 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $975 · 2025 $1,764
Food & beverage: $1,679Education: $85
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $359 |
| Lilly USA, LLC | 9 | $206 |
| Phathom Pharmaceuticals, Inc. | 16 | $204 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 10 | $181 |
| GENZYME CORPORATION | 6 | $154 |
| Ipsen Biopharmaceuticals, Inc | 6 | $125 |
| Aimmune Therapeutics, Inc. | 1 | $115 |
| Madrigal Pharmaceuticals | 3 | $91 |
| Janssen Biotech, Inc. | 1 | $85 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $82 |
Products named: OMVOH, VOQUEZNA, DUPIXENT, XIFAXAN, SKYRIZI, IQIRVO, ZENPEP, REZDIFFRA.
Industry payments across GA — which companies pay providers there.
